Average Co-Inventor Count = 3.50
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoechst Aktiengesellschaft (27 from 6,662 patents)
2. Aventis Pharma Deutschland, Gmbh (2 from 330 patents)
3. Hoechst Japan Limited (2 from 66 patents)
4. Celltech Limited (1 from 42 patents)
31 patents:
1. 6432968 - Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
2. 6214992 - Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
3. 6046328 - Combination preparation, containing cyclosporin A or FK506 or rapamycin
4. 5965555 - Xanthine compounds having terminally animated alkynol side chains
5. 5958413 - Use of antibodies to TNF or fragments derived thereof and xanthine
6. 5922868 - Use of xanthine derivatives for the treatment of nerve damage following
7. 5710272 - 7-methoxymethly-3-methyl-1-(5-oxohexyl)xanthine
8. 5478831 - R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its
9. 5472873 - Rhodotorula rubra useful in a process for the preparation of
10. 5409935 - Xanthine derivatives for the treatment of secondary nerve cell damage
11. 5407815 - R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its
12. 5310666 - Process for the enantioselective preparation of
13. 5109003 - Method for the treatment of peptic ulcer disease
14. 5082845 - Therapeutic xanthine derivatives for the treatment of peptic ulcer
15. 5006515 - Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles